Results 301 to 310 of about 211,619 (334)

Hesitancy toward Childhood and Influenza Vaccines: Experiences from Highly Educated Jordanian Parents. [PDF]

Vaccines (Basel)
Al-Iede M, Aljahalin M, Fashho E, Sweis S, Mesmeh R, Hamad LB, Abuzaid L, Sa'ed JA, Elbetar Y, Alabdali AYM, Al-Nawaiseh S, Al-Ani A.   +11 more
europepmc   +1 more source

Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical Trial.

JAMA Netw Open
Walter EB, Schlaudecker EP, Talaat KR, Rountree W, Broder KR, Duffy J, Grohskopf LA, Poniewierski MS, Spreng RL, Staat MA, Tekalign R, Museru O, Goel A, Davis GN, Schmader KE.   +14 more
europepmc   +1 more source

Mastoparan-7 adjuvanted COBRA H1 and H3 hemagglutinin influenza vaccines. [PDF]

Sci Rep
Sanchez PL, Staats HF, Abraham SN, Ross TM.   +3 more
europepmc   +1 more source

Advax-SM™-Adjuvanted COBRA (H1/H3) Hemagglutinin Influenza Vaccines. [PDF]

Vaccines (Basel)
Sanchez PL, Andre G, Antipov A, Petrovsky N, Ross TM.   +4 more
europepmc   +1 more source

Meeting Report From "Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID-19 Pandemic". [PDF]

Influenza Other Respir Viruses
Krammer F, Katz JM, Engelhardt OG, Post DJ, Roberts PC, Sullivan SG, Tompkins SM, Chiu C, Schultz-Cherry S, Cox RJ.   +9 more
europepmc   +1 more source

The potential global impact and cost-effectiveness of next-generation influenza vaccines: a modelling analysis

Goodfellow L, Procter SR, Koltai M, Waterlow NR, Filipe JAN, Wong CKH, van Leeuwen E, WHO Technical Advisory Group for the Full Value of Influenza Vaccines Assessment and project team, Next-generation influenza vaccine impact modelling contributors, Eggo RM, Jit M.   +10 more
europepmc   +1 more source

Stroke After Influenza Vaccines in Older Adults in the US, 2016 to 2019.

JAMA Netw Open
Lu Y, Matuska K, Ma Y, Laniyan L, Chillarige Y, Anderson SA, Forshee RA.   +6 more
europepmc   +1 more source